Matthias Templ delivered an invited presentation at the Statistics & Methodology platform meeting of the Swiss Clinical Trial Organisation held in Bern. His discussion centred on the Swiss Data Anonymization Competence Center and the anonymization and synthetization of data.
The presentation featured substantive dialogue regarding membership attacks targeting clinical trial datasets and potential disclosure risks inherent in typical clinical trial information. The discourse highlighted that clinical trial data present distinctive challenges: they frequently encompass information from fewer than 300 study participants and typically contain limited key variables alongside highly sensitive information.